These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28173160)

  • 1. Pathogenic inflammation in the CNS of mice carrying human PLP1 mutations.
    Groh J; Friedman HC; Orel N; Ip CW; Fischer S; Spahn I; Schäffner E; Hörner M; Stadler D; Buttmann M; Varallyay C; Solymosi L; Sendtner M; Peterson AC; Martini R
    Hum Mol Genet; 2016 Nov; 25(21):4686-4702. PubMed ID: 28173160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teriflunomide attenuates neuroinflammation-related neural damage in mice carrying human PLP1 mutations.
    Groh J; Hörner M; Martini R
    J Neuroinflammation; 2018 Jul; 15(1):194. PubMed ID: 29970109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting microglia attenuates neuroinflammation-related neural damage in mice carrying human PLP1 mutations.
    Groh J; Klein D; Berve K; West BL; Martini R
    Glia; 2019 Feb; 67(2):277-290. PubMed ID: 30565754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic dissection of oligodendroglial and neuronal Plp1 function in a novel mouse model of spastic paraplegia type 2.
    Lüders KA; Patzig J; Simons M; Nave KA; Werner HB
    Glia; 2017 Nov; 65(11):1762-1776. PubMed ID: 28836307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative proteomics, genomics, and translational immunology approaches reveal mutated forms of Proteolipid Protein 1 (PLP1) and mutant-specific immune response in multiple sclerosis.
    Qendro V; Bugos GA; Lundgren DH; Glynn J; Han MH; Han DK
    Proteomics; 2017 Mar; 17(6):. PubMed ID: 28191734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPG2 mimicking multiple sclerosis in a family identified using next generation sequencing.
    Rubegni A; Battisti C; Tessa A; Cerase A; Doccini S; Malandrini A; Santorelli FM; Federico A
    J Neurol Sci; 2017 Apr; 375():198-202. PubMed ID: 28320130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The good and the bad of neuroinflammation in multiple sclerosis.
    Naegele M; Martin R
    Handb Clin Neurol; 2014; 122():59-87. PubMed ID: 24507513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Intron 1 Sequences on Human PLP1 Expression: Implications for PLP1-Related Disorders.
    Wight PA
    ASN Neuro; 2017; 9(4):1759091417720583. PubMed ID: 28735559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible Expression of a Truncated Form of Tau in Oligodendrocytes Elicits Gait Abnormalities and a Decrease in Myelin: Implications for Selective CNS Degenerative Diseases.
    LoPresti P
    Neurochem Res; 2015 Nov; 40(11):2188-99. PubMed ID: 26394614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncoupling of neuroinflammation from axonal degeneration in mice lacking the myelin protein tetraspanin-2.
    de Monasterio-Schrader P; Patzig J; Möbius W; Barrette B; Wagner TL; Kusch K; Edgar JM; Brophy PJ; Werner HB
    Glia; 2013 Nov; 61(11):1832-47. PubMed ID: 24038504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eomes-expressing T-helper cells as potential target of therapy in chronic neuroinflammation.
    Oki S
    Neurochem Int; 2019 Nov; 130():104348. PubMed ID: 30508560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of human PLP1 expression through transcriptional regulatory elements and alternatively spliced exons in intron 1.
    Hamdan H; Kockara NT; Jolly LA; Haun S; Wight PA
    ASN Neuro; 2015; 7(1):. PubMed ID: 25694552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The myelin proteolipid DMα in fishes.
    Brösamle C
    Neuron Glia Biol; 2010 May; 6(2):109-12. PubMed ID: 19508742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis.
    Greer JM; Pender MP
    J Autoimmun; 2008 Nov; 31(3):281-7. PubMed ID: 18502611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLP1 splicing abnormalities identified in Pelizaeus-Merzbacher disease and SPG2 fibroblasts are associated with different types of mutations.
    Bonnet-Dupeyron MN; Combes P; Santander P; Cailloux F; Boespflug-Tanguy O; Vaurs-Barrière C
    Hum Mutat; 2008 Aug; 29(8):1028-36. PubMed ID: 18470932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of complicated spastic paraplegia 2 due to a point mutation in the proteolipid protein 1 gene.
    Lee ES; Moon HK; Park YH; Garbern J; Hobson GM
    J Neurol Sci; 2004 Sep; 224(1-2):83-7. PubMed ID: 15450775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms linking neuroinflammation and neurodegeneration in MS.
    Ellwardt E; Zipp F
    Exp Neurol; 2014 Dec; 262 Pt A():8-17. PubMed ID: 24530639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of SIRT-1 Signaling in Multiple Sclerosis and Neuroimmune Disorders: A Systematic Review of SIRTUIN Activators as Potential Immunomodulators and their Influences on other Dysfunctions.
    Sharma N; Shandilya A; Kumar N; Mehan S
    Endocr Metab Immune Disord Drug Targets; 2021; 21(10):1845-1868. PubMed ID: 33687904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current concepts of PLP and its role in the nervous system.
    Griffiths I; Klugmann M; Anderson T; Thomson C; Vouyiouklis D; Nave KA
    Microsc Res Tech; 1998 Jun; 41(5):344-58. PubMed ID: 9672418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spectrum of PLP1 gene mutations in patients with the classical form of the Pelizaeus-Merzbacher disease.
    Hoffman-Zacharska D; Mierzewska H; Szczepanik E; Poznański J; Mazurczak T; Jakubiuk-Tomaszuk A; Mądry J; Kierdaszuk A; Bal J
    Med Wieku Rozwoj; 2013; 17(4):293-300. PubMed ID: 24519770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.